Health
Penn Study Finds Solid-Tumor Cancer Patients Ineligible for Clinical Trials Receive Immunotherapy at Greater Rates Despite Lack of Benefits – Newswise
Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients…
Newswise — PHILADELPHIA — Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers at the…
Continue Reading
-
General17 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Noosa News24 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
General23 hours agoAustralia welcomes Gaza peace progress, hostage release
-
General15 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell